Contact Information

Intravenous Ketamine Clinic

Wang Building, CPC, Floor 3
55 Fruit Street
Boston, MA  02114

Phone: 617-724-5510
Fax: 617-643-9048

*Please note: On December 5, we moved to the Mass General Wang Building CPC Floor 3.

Appointments

Ketamine IV appointments are conducted in the Intravenous Ketamine Clinic on the Mass General main campus on Tuesday and Thursday evenings from 5:30 pm-8:30 pm. 

Internal Referrals: As of 08/01/22, we are accepting new patient referrals from MGB providers submitted via Epic (Ambulatory Referral to MGH Ketamine Clinic REF210291). 

Outside Referrals: Complete the referral form so we can determine whether the program is a good fit for the individual and gather relevant clinical information. A completed referral form is required prior to treatment.

Please send completed referral forms to mghketamineclinic@mgh.harvard.edu.

Explore This Treatment Program

    *Please note: On December 5, we moved to the Mass General Wang Building CPC Floor 3.

    The Intravenous Ketamine Clinic for Depression at Massachusetts General Hospital combines advanced psychopharmacology expertise with knowledge stemming from a decade of ketamine research. We offer treatment for patients 15 years and older with severe and refractory depression using the medication ketamine given through intravenous infusion or through the nose (intranasal). We work collaboratively with the outpatient treatment team to develop an appropriate plan for each patient.

    Our Focus

    As a part of the Depression Clinical and Research Program at Mass General, we are committed to advancing our knowledge and ability to treat depression by integrating clinical care and innovative research. We do this through a number of avenues:

    • Our consultation services
    • The ketamine intravenous (IV) infusion service and intranasal ketamine clinic
    • Research studies focused on ketamine treatment

    After a thorough consultation process, we offer IV infusions and intranasal ketamine maintenance to patients with severe depression or chronic suicidal ideation.

    Infusion Treatment

    Payment

    Ketamine treatment may be covered by your insurance, but to be sure please contact your insurer for updated information. The coverage of ketamine treatments is rapidly evolving at this time.

    • Nathan Praschan, MD
    • Sahand BabapoorFarrokhran, MD (Clinical Fellow)
    • Yoonju Cho, MD (Clinical Fellow)

     

    Our Research

    Grants

    Publications

    Presentations

    • Ketamine Non-Responders Exhibit Pathological Increases in Extracellular Free Water Following Treatment–New Evidence of Astrocyte Pathology in Depression. Peyda S, Sydnor VJ, Kubicki M, Karayumak SC, Cheung J, Felicione JM, Shenton ME, Akeju-Johnson O, Pasternak O, Deckersbach T, Cusin C. Annual Meeting of American Society Clinical Pathology, Miami, May 29-June 1, 2018
    • Gender Differences in the Response to and Tolerability of Ketamine as a Treatment for Acute Depression. Freeman MP, Papakostas G, Hoeppner B, Mazzone E, Judge H, Cusin C, Mathew S, Sanacora G, Iosifescu D, Trivedi M, Fava M. Annual Meeting of American Society Clinical Pathology, Miami, May 29-June 1, 2018

    Department of Psychiatry

    For 80 years, Mass General's Psychiatry Department has provided the highest quality patient care through pioneering research.

    Learn more
    60

    Over 60 specialty psychiatry clinical and research programs

    We provide care for patients of any age throughout the lifespan.

    Explore programs

    Depression Clinical & Research Program

    The Depression Clinical and Research Program provides care to patients in need and conducts research to make depression treatable and preventable.

    Learn more